Liang Du
Impact in
- Hepatology top 1%
- Hepatocellular Carcinoma Treatment and Prognosis
- Liver Disease and Transplantation
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Meta-analysis and systematic reviews 14
Liang Du
154 papers receiving 3.4k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Hepatology 620
- Cancer Research 356
- Biochemistry 138
- General Dentistry 34
- Oncology 507
Countries citing papers authored by Liang Du
This map shows the geographic impact of Liang Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liang Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liang Du more than expected).
Fields of papers citing papers by Liang Du
This network shows the impact of papers produced by Liang Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liang Du. The network helps show where Liang Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Liang Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 8 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2024 | 5 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 3 | |
| 8 | 2024 | 12 | |
| 9 | 2024 | 0 | |
| 10 | 2024 | 10 | |
| 11 | 2024 | 1 | |
| 12 | 2023 | 25 | |
| 13 | 2020 | 3 | |
| 14 | 2019 | 29 | |
| 15 | miR-30a suppresses osteosarcoma proliferation and metastasis by downregulating MEF2D expression | 2018 | 1 |
| 16 | Comparative efficacy and safety of Crocus sativus L. for treating mild to moderate major depressive disorder in adults: a meta-analysis of randomized controlled trials | 2018 | 2 |
| 17 | 2016 | 11 | |
| 18 | A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria Hit paper breakdown → | 2010 | 610 |
| 19 | Determination of Time-of-Use Retail Price in the Retail Market | 2008 | 4 |
| 20 | Algorithm Research Based on DF and Location | 2004 | 0 |
About Liang Du
Liang Du is a scholar working on Statistics, Probability and Uncertainty, Health Informatics, Applied Microbiology and Biotechnology, Complementary and alternative medicine and Otorhinolaryngology, having authored 170 papers that have together received 3.5k indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (14 papers), RNA modifications and cancer (6 papers), Surgical Sutures and Adhesives (6 papers), Health Systems, Economic Evaluations, Quality of Life (6 papers), Nutritional Studies and Diet (6 papers), Heat Transfer and Optimization (5 papers), Glutathione Transferases and Polymorphisms (4 papers) and Complementary and Alternative Medicine Studies (4 papers). The work is most often cited by research in Hepatology (620 citations), Cancer Research (356 citations), Biochemistry (138 citations), General Dentistry (34 citations) and Oncology (507 citations). Liang Du has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yong Zhou, Lvnan Yan, Yong Zeng, Yinglong Xu, Hong Wu, Jinzhou Wang, Zheyu Cheng, Jiwei Huang, Xiaoting Wu and Jin Huang. Their work appears in journals such as Journal of Evidence-Based Medicine, Tumor Biology, Medicine, Digestive Diseases and Sciences and Diamond and Related Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.